SUMMARY The propagation velocity of evoked muscle spikes was measured and normal values are presented. Carbamazepine, phenobarbitone, diazepam, and bromide-containing drugs were tested for their effect on conduction velocity of motor nerve and skeletal muscle fibres. All these drugs caused a decrease in spike propagation, both of motor nerves and skeletal muscle. After discussion of the probable mode and site of action of these drugs, it was supposed that the underlying eventsperhaps changes in permeability of excitable membranes during excitation-are an essential factor in the anticonvulsant action of these drugs.
The anticonvulsant action of certain drugs must be due to their effect on the electrical activity of nervous tissue. The majority of investigations concerning these drugs have been confined to testing their influence on polysynaptic pathways and evidence has been gained that synaptic transmission is depressed (Goodman and Gilman, 1970) . Some findings in experimental animals (Toman, 1949; Korey, 1951; Morrell, Bradley, and Ptashne, 1958) , however, as well as clinical observations (Lovelace and Horwitz, 1968) , have pointed to the fact that, for example, diphenylhydantoin might induce impairment of the function of lower motor neurones. Corresponding changes have been observed in peripheral nerves exposed to barbiturates (Heinbecker and Bartley, 1940) . In both cases the site of action appears to be the excitable membrane (Thesleff, 1956; Pincus, 1972) .
In 1967, and in more detail in 1968, Hopf reported on 13 patients, who developed a slight but definite decrease of motor nerve conduction velocity after treatment with high-normal doses of diphenylhydantoin. His observations were supplemented by Kauer and Hopf (1971) , who demonstrated that diphenylhydantoin also reduces the conduction velocity of skeletal muscle fibres. From these findings the question arose as to whether other drugs commonly used in treatment of epilepsy might have similar 'side'-effects on the electrical properties of motor 574 nerves and muscle fibres, in particular on the propagation of their action potentials.
METHODS
Propagation velocity of evoked muscle fibre action potentials was estimated using the method of Buchthal, Guld, and Rosenfalck (1955) . The stimulus current was a rectangular impulse, 0 05 to 0 1 msec in duration, delivered by a battery operated stimulator. The stimulating cathode was an insulated steel needle, 0-2 mm in diameter and with a bared tip of 0-5 mm. It was placed into the muscle tissue at the distal quarter of the brachial biceps muscle. The anode was an uninsulated steel needle placed subcutaneously about 30 mm distal to the cathode.
Uninsulated steel needles with diameter of 0-2 mm were also used as recording electrodes. Two 'active' electrodes were placed at two sites proximal to the stimulating electrode within a distance of about 30-35 mm and 60-75 mm respectively. The corresponding indifferent electrodes were placed subcutaneously, lateral to the active electrodes at the same level and 40-50 mm apart.
The positions of the two active electrodes were changed until a single small muscle spike appeared and disappeared simultaneously at both sites while increasing and decreasing the stimulus strength (Fig. 1) In 59 healthy subjects of the same age group 370 electrically evoked small muscle action potentials were evaluated. The average velocity of spike propagation was 4-22 m/sec (SD 0-58 m/sec). The corresponding histogram is shown in Fig. 2 . The tissue temperature was 36 3°C (SD 0-4°C) when the examination started and 35-9°C (SD 0-510C) when it was finished. A delay in conduction time corresponding to the slight drop in muscle temperature was not observed.
EFFECT OF CARBAMAZEPINE (see Table) Carbamazepine (Tegretol) was tested in 18 subjects during oral administration of 1,000 mg a day. After a period of five days the maximum motor conduction velocity of the ulnar nerve was significantly decreased from 60-9 m/sec to 56-7 m/sec ( 70%). Muscle fibre conduction velocity was evaluated in nine subjects. The mean velocity initially was 4-61 m/sec and after the five days period it was significantly reduced to 4-31 m/sec (-6.5%). Serum levels of the drug were not determined for technical reasons. Table) There were 29 subjects receiving phenobarbitone Table) Diazepam (Valium) 40 mg a day, was given to 20 subjects.
INFLUENCE OF PHENOBARBITONE (see
The mean motor nerve conduction velocity of 57.4 m/sec was decreased to 54 1 m/sec after three days of treatment (-5-5%°) (Fig. 4) .
Muscle conduction velocity was not tested. Slowing of muscle spike propagation, however, was suggested by the fact that the duration of the negative deflection of the evoked muscle response increased from 5-41 msec (SD 0-71 msec) to 6-05 msec (SD 0-93 msec). Changes of the negative deflection of the compound action potential have been accepted as indicating changes in muscle fibre conduction velocity (Desmedt, 1958) .
BROMINE-CONTAINING DRUGS AND MUSCLE FIBRE
CONDUCTION VELOCITY (see Table) Three patients suffering from bromide intoxication were tested for muscle fibre conduction velocity. (Buchthal et al., 1955) . However, if nerve rather than muscle fibre velocity were estimated, then the fibres concerned would have to be unmyelinated or very finely myelinated fibres extending over a distance of 3-5 to 7 cm to give the velocities obtained. To our knowledge, however, there is The mean value of 4-22 m/secs for muscle spike propagation velocity as reported here is slightly higher than that reported by Buchthal et al. (1955) . The difference is probably due to the fact that a considerably larger number of fibres was evaluated by us. This factor probably also partly accounts for the wider range of velocities (Kauer and Hopf, 1971) .
The figures of Stalberg (1966) , using a different technique, show a comparable wide range of conduction velocities (2-0-6-5 m/sec). The mean value, however, given by him is 0 53 m/sec lower than the value calculated from our results. The difference between Stalberg's and our own findings is due to the fact that he found a greater number of slow conducting fibres. There are three possible explanations for this. (1) As far as can be concluded from the illustrations, Stalberg (1966) recorded from a more distal part of the muscle than we did. Thus, he might have recorded a considerable number of spikes from the tapering end of the spindle-shaped muscle fibres where the spike is expected to be propagated at a lower speed. (2) Stalberg found that conduction velocity decreased with increasing firing rates. Action potential spikes from voluntarily activated fibres were measured by him and their repetition rates varied between 5 and 20 impulses per second. In seven muscle fibres the initial values were 0-42 m/sec faster than after repetitive activation (4-03 m/sec as compared with 3-6 m/sec). In our experiments, however, the muscle was stimulated at rates between 0-2 to 1 -0/sec where a decrease of the velocity does not take place. (3) It has already been mentioned that with Buchthal's method some slowly conducted spikes might have escaped detection because of being hidden in a compound evoked response.
The skin and tissue temperatures remained almost unchanged throughout the experiment. There was only a slight drop in tissue temperature of 0 4°C during the individual experiments. According to Hakansson (1954) this should have caused a decrease in conduction velocity of 0 04 m/sec. A corresponding delay of the muscle spike, however, was not found. We have so far been unable to explain this finding. The possibility that the differences in conduction velocity of motor nerves and muscle fibres reported here were mainly or pai tly caused by an indirect effect of the tested drugs on body temperature can be ruled out, as tissue and skin temperature remained unchanged or were slightly increased.
The drug-induced decrease of conduction velocity varied between 4.500 (phenobarbitone) and 8% (diphenylhydantoin) for the fastest motor nerve fibres and between 400 (diphenylhydantoin) and 6.5% (carbamazepine) for the skeletal muscle fibres. We would like to stress that such delays in spike propagation were found with drug doses which are sometimes (carbamazepine) or commonly (diazepam, phenobarbitone) used in the treatment of epilepsy and tic douloureux.
A much greater decrease (of about 19%) was found in the patients suffering from bromide intoxication. In these patients, however, very abnormal conditions were present, with signs of severe intoxication such as electroencephalographic (EEG) abnormalities and mental disability, and in two of them hallucinatory episodes were observed.
The drugs which are dealt with in this study influence the electrical activity of nervous tissue (Goodman and Gilman, 1970) . The influences on the EEG and/or on synaptic transmission are well known (Heinbecker and Bartley, 1940; Wikler, 1945; Stille, 1955; Caspers and Weymeyer, 1957; Morrell et al., 1958; Domino, 1962; Esplin, 1963; L0yning, Oshime, and Yokota, 1964; Norris, Colella, and McFarlin, 1964; Schallek, Zabransky, and Kuehn, 1964; Engle, 1966; Miyahara, Esplin, and Zabloska, 1966; Ngai, Tseng, and Wang, 1966; Fromm and Killian, 1967; Kolant and Grose, 1967; Marjerrison, Jedlicki, Keough, Hrychuik, and Poulakis, 1968; Przybyla and Wang, 1968; and others). But the mode of action on individual nerve cells has only been established so far for barbiturates and diphenylhydantoin (Blaustein, 1968; Pincus, 1972 Thesleff (1956) investigated the influence of pentobarbitone on the isolated frog nerve-muscle preparation. Pentobarbitone reduced the amplitude of the miniature endplate potentials without affecting their rate of discharge, increased the threshold to electrical stimuli, and caused marked reduction of the action potential amplitude but left the resting membrane potential unaffected. His conclusions are that the ion permeability occurring during excitation is reduced by barbiturates.
As early as 1940 Heinbecker and Bartley demonstrated that when frog sciatic nerve was exposed to pentobarbitone sodium the amplitude of individual axon spikes was depressed without changing their duration, the conduction velocity was decreased, and the absolute refractory period was prolonged.
In all these experiments amounts of barbiturates were used that would cause severe intoxication in man. Our findings, however, confirm that comparable effects, though to a lesser degree, are present even with drug amounts not producing toxic symptoms. Pincus (1972) stated that diphenylhydantoin at concentrations of 1.0x 10-4 M to 5-0x 10-4 M reduces the influx of 24Na into stimulated lobster nerves by 4000. There was no effect on the potassium uptake in stimulated nerves, nor on the sodium influx under resting conditions, and no effect on the sodium efflux in resting or stimulated nerves.
These changes in ion permeability during excitation would easily explain the action of diphenylhydantoin on nerve and muscle. Ritchie (1971) found that the size ofthe compound action potential of desheathed vagus nerves was reduced. Sasynik and Dresel (1968) reported that in the isolated dog heart the A-V conduction time and propagation within the bundle of His was delayed. According to Kauer and Hopf (1971), and the propagation velocity of skeletal muscle fibres and of motor nerves is decreased.
Detailed studies have not been performed for diazepam and carbamazepine. Diazepam depresses the afterdischarge in the limbic system, blocks convulsions induced by strychnine or pentylenetetrazol, and influences the activity of the brain-stem reticular formation (Przybyla and Wang, 1968) . The effect of carbamazepine on the spinal trigeminal nucleus is similar to that of diphenylhydantoin (Fromm and Killian, 1967) . It has been demonstrated that both drugs reduce the conduction velocity of motor nerves and muscle fibres. Their action actually did not differ from the action of diphenylhydantoin and phenobarbitone. Thus, it seems possible that the same mechanismthe influence on ion permeability-might be involved in the effect of diazepam and carbamazepine.
In respect to the action of bromides we can only refer to the paper of Brattgard and Lindqvist (1954) who demonstrated that 82Br invades nerve cells and is deposited in the cytoplasm and the nucleus. There is, however, no suggestion as to the mode of action on muscle spike propagation.
As decreasing motor nerve conduction velocity and/or muscle spike propagation is a consistent feature of all the anticonvulsant drugs tested so far, we feel that the underlying events-perhaps changes in ion permeability during excitationrepresent the essential factor in their anticonvulsant-action.
